Tilianin suppresses a person's ovarian cancer malignancy (PA-1) cell expansion by way of preventing cell routine, causing apoptosis and also conquering JAK2/STAT3 signaling pathway.
Tilianin suppresses a person's ovarian cancer malignancy (PA-1) cell expansion by way of preventing cell routine, causing apoptosis and also conquering JAK2/STAT3 signaling pathway.